Mel Mann, 31-year terminal Chronic Myeloid Leukemia (CML) Survivor, Clinical Trial Pioneer, and Patient Advocate, shared on X:
“I was given 3 years. I didn’t wait for a perfect option.
I took the one that existed – a Phase 1 trial for a drug that didn’t even have a real name yet.
That choice bought me decades. It let me watch my daughter become a physician. It put me back on a marathon course ten months later.
I am Exhibit A. Clinical trials are how you get tomorrow’s medicine today.”
Other articles featuring Mel Mann on OncoDaily.